T

Tyche Industries Ltd
BSE:532384

Watchlist Manager
Tyche Industries Ltd
BSE:532384
Watchlist
Price: 120 INR -0.87%
Market Cap: 1.2B INR

Tyche Industries Ltd
Investor Relations

Tyche Industries Ltd. engages in the manufacture and processing of active pharmaceutical ingredients and intermediates. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2000-09-25. The firm primarily manufactures bulk drug intermediates. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal. Its intermediaries include 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thiophene, 3-Fluoro-4-methoxy acetophenone, 3-Hydroxymethyl quinuclidine HCl, (RS)-3-Quinuclidinol, 3-Quinuclidinone Hydrochloride and 1-Benzylpiperidine-4-Carboxaldehyde (BPCA). Its nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Ganesh Kumar Gokaraju
Chairman & MD
No Bio Available
Mr. Satya Ranjan Jena
Company Sec. & Compliance Officer
No Bio Available
Mr. G. Sandeep Kumar
Additional Exec. Director
No Bio Available

Contacts

Address
TELANGANA
Hyderabad
C-21/A, Road No.9,Film Nagar, Jubileehills
Contacts